International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 5 , Pages 1358-1363 , 1 April 2009

No Salvage Using High-Dose Chemotherapy Plus/Minus Reirradiation for Relapsing Previously Irradiated Medulloblastoma

  • Maura Massimino, M.D.

      Affiliations

    • Division of Pediatrics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • Corresponding Author InformationReprint requests to: Maura Massimino, M.D., Pediatric Oncology Unit, Istituto Nazionale Tumori, Via Venezian, 1 20133 Milano, Italy. Tel: (+39) 022-390-2593-2588; Fax: (+39) 022-390-2648
    • ,
  • Lorenza Gandola, M.D.

      Affiliations

    • Division of Radiotherapy, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Filippo Spreafico, M.D.

      Affiliations

    • Division of Pediatrics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Veronica Biassoni, M.D.

      Affiliations

    • Division of Pediatrics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Roberto Luksch, M.D.

      Affiliations

    • Division of Pediatrics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Paola Collini, M.D.

      Affiliations

    • Division of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Carlo N. Solero, M.D.

      Affiliations

    • Neurosurgery II, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
    • ,
  • Fabio Simonetti, M.D.

      Affiliations

    • Division of Pediatrics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Emanuele Pignoli, M.D.

      Affiliations

    • Division of Physics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Graziella Cefalo, M.D.

      Affiliations

    • Division of Pediatrics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Geraldina Poggi, M.D.

      Affiliations

    • Acquired Lesion Unit, Eugenio Medea Institute, Bosisio Parini, Italy
    • ,
  • Piergiorgio Modena, Ph.D.

      Affiliations

    • Division of Cytogenetics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Luigi Mariani, M.D.

      Affiliations

    • Division of Statistics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Paolo Potepan, M.D.

      Affiliations

    • Division of Radiology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Marta Podda, M.D.

      Affiliations

    • Division of Pediatrics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Michela Casanova, M.D.

      Affiliations

    • Division of Pediatrics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Emilia Pecori, M.D.

      Affiliations

    • Division of Radiotherapy, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Stefania Acerno, M.D.

      Affiliations

    • Pediatric Neurosurgery Unit, San Raffaele Hospital, Milan, Italy
    • ,
  • Andrea Ferrari, M.D.

      Affiliations

    • Division of Pediatrics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Monica Terenziani, M.D.

      Affiliations

    • Division of Pediatrics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Cristina Meazza, M.D.

      Affiliations

    • Division of Pediatrics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Daniela Polastri, M.D.

      Affiliations

    • Division of Pediatrics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Fernando Ravagnani, M.D.

      Affiliations

    • Division of Transfusional, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
    • ,
  • Franca Fossati-Bellani, M.D.

      Affiliations

    • Division of Pediatrics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy

Received 23 May 2008 ,Revised 17 June 2008 ,Accepted 18 June 2008.

References 

  1. Schellong G, Dörffel W, Claviez A, et al. Salvage therapy of progressive and recurrent Hodgkin's disease: Results from a multicenter study of the pediatric DAL/GPOH-HD study group. J Clin Oncol. 2005;23:6181–6189
  2. Messina C, Cesaro S, Rondelli R, et al. Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in Italy. AIEOP/FONOP-TMO Group. Italian Association of Paediatric Haemato-Oncology. Bone Marrow Transplant. 1998;21:1015–1021
  3. Finlay JL. The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors. Bone Marrow Transplant. 1996;18(Suppl.):S1–S5
  4. Finlay JL, Goldman S, Wong MC, et al. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. Children's Cancer Group. J Clin Oncol. 1996;14:2495–2503
  5. Gururangan S, Dunkel IJ, Goldman S, et al. Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors. J Clin Oncol. 1998;16:2486–2493
  6. Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:457–481
  7. Peto R, Peto J. Asymptomatically efficient rank invariant test procedures. J R Stat Soc [A]. 1972;135:185–207
  8. Fossati Bellani F, Gasparini M, Lombardi F, et al. Medulloblastoma. Results of a sequential combined treatment. Cancer. 1984;54:1956–1961
  9. Spreafico F, Massimino M, Gandola L, et al. Survival of adults treated for medulloblastoma using paediatric protocols. Eur J Cancer. 2005;41:1304–1310
  10. Cefalo G, Gandola L, Massimino M, et al. Intensive sequential chemotherapy (CT) plus hyperfractionated-accelerated radiotherapy (HART) for metastatic medulloblastoma: Preliminary results. [Abstract] Neurooncology. 2001;3(Suppl. 1):S64
  11. Packer RJ, Gajjar A, Velina G, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24:4202–4208
  12. Bouffet E, Doz F, Demaille MC, et al. Improving survival in recurrent medulloblastoma: Earlier detection, better treatment or still an impasse?. Br J Cancer. 1998;77:1321–1326
  13. Ridola V, Grill J, Doz F, et al. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy. Cancer. 2007;110:156–163
  14. Zia MI, Forsyth P, Chaudhry A, et al. Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma. Bone Marrow Transplant. 2002;30:565–569
  15. Pérez-Martínez A, Lassaletta A, González-Vicent M, et al. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neurooncol. 2005;71:33–38
  16. Valteau-Couanet D, Fillipini B, Benhamou E, et al. High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: High toxicity and lack of efficacy. Bone Marrow Transplant. 2005;36:939–945
  17. Cheuk DK, Lee TL, Chiang AK, et al. Autologous hematopoietic stem cell transplantation for high-risk brain tumors in children. J Neuro Oncol. 2008;86:337–347
  18. Shih CS, Hale GA, Gronewold L, et al. High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors. Cancer. 2008;112:1345–1353
  19. Balter-Seri J, Mor C, Shuper A, et al. Cure of recurrent medulloblastoma: The contribution of surgical resection at relapse. Cancer. 1997;79:1241–1247
  20. Kalifa C, Hartmann O, Demeocq F, et al. High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: A phase 2 study. Bone Marrow Transplant. 1992;9:227–233
  21. Mason WP, Grovas A, Halpern S, et al. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol. 1998;16:210–221
  22. Heideman RL, Cole DE, Balis F, et al. Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: Evidence for dose-dependent plasma clearance of thiotepa. Cancer Res. 1989;49:736–741
  23. Ashley DM, Meier L, Kerby T, et al. Response of recurrent medulloblastoma to low-dose oral etoposide. J Clin Oncol. 1996;14:1922–1927
  24. Chamberlain MC, Kormanik PA. Chronic oral VP-16 for recurrent medulloblastoma. Pediatr Neurol. 1997;17:230–234
  25. Durando X, Thivat E, Gilliot O, et al. Temozolomide treatment of an adult with a relapsing medulloblastoma. Cancer Invest. 2007;25:470–475
  26. Nicholson HS, Kretschmar CS, Krailo M, et al. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors. Cancer. 2007;110:1542–1550
  27. Saran F, Baumert BG, Creak AL, et al. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET. Pediatr Blood Cancer. 2008;50:554–560

 Supported in part by the Associazione Italiano perla Ricerca Sul Cancro and Associazione Bianca Garavaglia (Busto Arsizio Varese).

 Conflict of interest: none.

PII: S0360-3016(08)02972-6

doi: 10.1016/j.ijrobp.2008.06.1930

International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 5 , Pages 1358-1363 , 1 April 2009

Article Tools

* Image Usage & Resolution